PALB2 has been confirmed asa high-risk BC susceptibility gene in recent large-scale analyses of multigene paneltesting, with the odds ratio of PALB2 mutations for BC beingcomparable to that of BRCA2 mutations (28,29). This evidence concerns the gene BRCA2 and breast cancer.